New Delhi/Alive News: New prices of 137 anti-cancer drugs came into effect across the country on Monday, November 9, following a decision by the National Pharmaceutical Pricing Authority (NPPA) to regulate trade margins and make cancer medicines more affordable.
According to the NPPA, 85 pharmaceutical companies had submitted revised prices for 1,364 formulations covering 121 anti-cancer drugs by November 8. The revision follows recommendations made by an expert committee constituted by the Directorate General of Health Services on October 17.
The price reduction exceeds 50 per cent for 679 brands, while the highest reported reduction stands at 96.45 per cent. The move is expected to save consumers approximately ₹3,540.38 crore annually.
Consumers Can Check Revised Medicine Prices
Consumers can check the revised maximum retail price (MRP) printed on medicine packs. Prices can also be verified through the Pharma Sahi Daam mobile application or the NPPA website, nppa.gov.in.
Chemists and hospital pharmacies are not permitted to charge more than the applicable revised MRP.
Where to Complain Against Overcharging
Consumers who are charged more than the prescribed MRP can register complaints through the Pharma Jan Samadhan portal. They can also contact the NPPA helpline at 1800-111-255.
How Are Medicine Prices Fixed?
Under the Drug Price Control Order (DPCO), 2013, the government fixes ceiling prices for medicines included in the National List of Essential Medicines (NLEM).
The Health Ministry prepares the list based on factors such as safety, effectiveness, affordability and healthcare requirements. It is reviewed periodically, with new medicines added when necessary.
